Michael Bass, Global Medical Director of Viome Dx, shared a post on LinkedIn:
“Sweden just screened 278,000 people for colon cancer in the largest randomized trial ever done. The results should make you pick up the phone and schedule your colonoscopy.
Colonoscopy caught 38% more early-stage cancers. FIT stool tests caught 19% more. Advanced cancers dropped in both groups.
Why does that matter? Because in colorectal cancer, when you’re found is everything. Stage I caught on a routine scope? Surgery, done, back to your life.
Stage IV found because you finally went to the ER with symptoms? Chemo, radiation, and a fight for survival.
Critics will correctly point out the trial hasn’t shown a mortality benefit yet. It’s a 15-year study with data coming in 2030. But when you shift cancers from late stage to early stage, we already know what happens. We’ve seen it with every screening program that works.
The best screening test is the one you actually do. Colonoscopy or FIT, just pick one.”
Other articles featuring Michael Bass on OncoDaily.